COPD News

NEW ORLEANS - The GOLD guidelines are a tool that can help decide the best therapy for patients with COPD, according to Alan Dow, MD, MSHA, a general internist at Virginia Commonwealth University and member of the ACP Internal Medicine Meeting planning committee.

Infants with bronchiolitis who are treated with high-flow oxygen therapy are less likely to require increased care when compared with infants who receive standard oxygen therapy, according to a study published in The New England Journal of Medicine.

ORLANDO, Fla. – COPD is one of the most common conditions associated with hospital readmission, and many of these may be preventable, according to a presentation here at Hospital Medicine 2018.

Although measles infection during childhood is not independently linked to chronic obstructive pulmonary disease — or post-bronchodilator airflow obstruction —  the infection can strengthen the association between smoking, current asthma and post-bronchodilator airflow obstruction.

Patients who used long-term inhaled corticosteroids to treat their COPD were at moderately higher risk for upper extremity and hip fractures, according to findings published in Chest.

Follow-up visits scheduled for younger children who had been hospitalized for bronchiolitis offered reassurance for families, according to recently published study results in JAMA Pediatrics.

AstraZeneca recently announced that the FDA has approved once-daily Daliresp 250 µg as a starting dose for the initial 4 weeks followed by 500 µg to reduce treatment discontinuation in patients with severe COPD.

New use of long-acting beta 2-agonists and long-acting muscarinic antagonists in patients with COPD was associated with a 1.5-fold increased risk for cardiovascular disease within 30 days of initiation, according to data published in JAMA Internal Medicine.

Older adults who were treated for asthma or COPD with inhaled corticosteroids were twice as likely to develop nontuberculous mycobacterial pulmonary disease infections than those who were not, according to findings published in the European Respiratory Journal.

Inappropriate antibiotic prescribing rates increased 12 months after behavioral interventions stopped when compared with control practices, according to findings recently published in JAMA.